Bio-Tech Medical Software

Forian Inc. (NASDAQ: FORA) announced the sale of its cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., effective February 10, 2023, for a total purchase price of $30 million in cash, comprised of $20 million paid at closing and $10 million paid in...

Bio-Tech Medical Software, Inc. subsidiary of Forian Inc. (NASDAQ: FORA), successfully completed the launch of its New Mexico state traceability system for adult-use cannabis sales. This latest state partnership demonstrates the continued expansion of Forian’s BioTrack state traceability...